CD8A and neoplasm: Using H2-Kb/SIINFEKL-pentamer staining, we identified endogenous OVA-specific CD8+ T cells in the tumor, tumor-draining lymph node (TdLN), and adjacent skin 30–40 days after tumor induction – with highest frequencies in the tumor (Figure 2F).